Detalhe da pesquisa
1.
Whole blood transcriptome signature predicts severe forms of COVID-19: Results from the COVIDeF cohort study.
Funct Integr Genomics
; 24(3): 107, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38772950
2.
Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.
Eur Respir J
; 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331460
3.
Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study.
Eur Respir J
; 61(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265877
4.
Early shoulder-girdle MRI findings in severe COVID-19-related intensive care unit-acquired weakness: a prospective cohort study.
Eur Radiol
; 33(7): 4994-5006, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36912923
5.
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
J Allergy Clin Immunol
; 149(2): 550-556.e2, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34800432
6.
Impact of a high emergency lung transplantation programme for cystic fibrosis in France: insight from a comparison with Canada.
Eur Respir J
; 59(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140297
7.
Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients.
Ther Drug Monit
; 43(1): 131-135, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230045
8.
Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19.
Int J Mol Sci
; 22(14)2021 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34299080
9.
Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis.
Eur Respir J
; 61(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455960
10.
Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France.
Am J Respir Crit Care Med
; 205(5): 584-586, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910604
11.
Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.
Ann Rheum Dis
; 80(3): e37, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32503849
12.
Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients.
J Clin Med
; 11(19)2022 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233427
13.
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients.
Clin Microbiol Infect
; 28(12): 1654.e1-1654.e4, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35926762
14.
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.
Sci Rep
; 11(1): 11886, 2021 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088975
15.
Platelet activation in critically ill COVID-19 patients.
Ann Intensive Care
; 11(1): 113, 2021 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273008
16.
COVID-19 in Lung Transplant Recipients.
Transplantation
; 105(1): 177-186, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33141808
17.
Determining extent of COVID-19 pneumonia on CT based on biological variables.
Respir Med
; 175: 106206, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33166904
18.
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
BMJ
; 369: m1844, 2020 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409486
19.
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Science
; 369(6504): 718-724, 2020 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661059